Technical Analysis for ELDN - Eledon Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 10.67 -5.74% -0.65
ELDN closed down 0.96 percent on Thursday, April 15, 2021, on 32 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat
Historical ELDN trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion -5.74%
Death Cross Bearish -6.65%
Wide Bands Range Expansion -6.65%
Outside Day Range Expansion -4.99%
Wide Bands Range Expansion -4.99%
Narrow Range Bar Range Contraction 0.85%
Wide Bands Range Expansion 0.85%
Down 3 Days in a Row Weakness 0.85%
Narrow Range Bar Range Contraction -4.13%
Wide Bands Range Expansion -4.13%
Older End-of-Day Signals for ELDN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 1 hour ago
Fell Below Previous Day's Low about 1 hour ago
60 Minute Opening Range Breakdown about 2 hours ago
Down 3% about 3 hours ago
Down 2 % about 4 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eledon Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. The company's lead product is OP0201, a surfactant-based nasal aerosol drug-device combination product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). It also has a foam-based drug delivery technology OP0101 and OP0102 that could be used to deliver drugs into the ear, nose, and sinus cavities. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Health Sciences Medication Infection Disorders Sinus Audiology Otorhinolaryngology Pediatrics Pernix Therapeutics Holdings

Is ELDN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 27.32
52 Week Low 6.1578
Average Volume 73,803
200-Day Moving Average 14.47
50-Day Moving Average 14.33
20-Day Moving Average 11.73
10-Day Moving Average 11.35
Average True Range 1.10
ADX 15.48
+DI 18.40
-DI 24.01
Chandelier Exit (Long, 3 ATRs ) 13.27
Chandelier Exit (Short, 3 ATRs ) 12.50
Upper Bollinger Band 14.26
Lower Bollinger Band 9.21
Percent B (%b) 0.42
BandWidth 43.03
MACD Line -0.84
MACD Signal Line -0.99
MACD Histogram 0.1496
Fundamentals Value
Market Cap 16.26 Million
Num Shares 1.44 Million
EPS -1.70
Price-to-Earnings (P/E) Ratio -6.65
Price-to-Sales 0.00
Price-to-Book 1.69
PEG Ratio 0.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.73
Resistance 3 (R3) 12.67 12.15 12.49
Resistance 2 (R2) 12.15 11.79 12.17 12.42
Resistance 1 (R1) 11.73 11.57 11.47 11.79 12.34
Pivot Point 11.21 11.21 11.08 11.24 11.21
Support 1 (S1) 10.79 10.85 10.53 10.85 10.30
Support 2 (S2) 10.27 10.63 10.30 10.22
Support 3 (S3) 9.85 10.27 10.15
Support 4 (S4) 9.91